|
Network Combined Dataset - Statins/MACE |
Statins and MACE |
|
Case, Control |
|
|
|
|
|
Geisinger Implementation |
Statins and MACE |
Geisinger |
Case, Control |
|
|
|
|
|
Statins and MACE: request for lipids lab data sep2015 |
Statins and MACE |
GHRI/UW |
Case, Control |
|
|
|
|
|
Harvard Implementation |
Statins and MACE |
Partners Healthcare |
Case, Control |
214 |
1,113 |
|
|
|
Statin and MACE Implementation - Columbia |
Statins and MACE |
Columbia University |
Case, Control |
41 |
570 |
|
|
|
ADHD Validation (CCHMC) |
ADHD phenotype algorithm |
Cincinnati Children's Hospital Medical Center |
Case, Control |
|
|
89%, 95% |
|
|
CHOP implementation |
ADHD phenotype algorithm |
CHOP |
Case, Control |
|
|
96%, 96% |
|
|
Harvard ADHD |
ADHD phenotype algorithm |
|
Case, Control |
80 |
1,581 |
|
|
|
ADHD Implementation - Columbia |
ADHD phenotype algorithm |
Columbia University |
Case, Control |
5 |
1,294 |
|
|
|
Atopic Dermatitis - Harvard |
Atopic Dermatitis Algorithm |
Harvard Medical School |
Case, Control |
72 |
1,037 |
|
|
|
Atopic Dermatitis - Columbia |
Atopic Dermatitis Algorithm |
Columbia University |
Case, Control |
7 |
238 |
|
|
|
Atopic Dermatitis |
Atopic Dermatitis Algorithm |
Cincinnati Children's Hospital Medical Center |
Case Only |
|
|
|
|
|
Atopic dermatitis implementation - Marshfield |
Atopic Dermatitis Algorithm |
Marshfield Clinic Research Foundation |
Case, Control |
|
|
96%, 90% |
|
|
Vanderbilt Implementations of Atopic Dermatitis |
Atopic Dermatitis Algorithm |
Vanderbilt University |
Case, Control |
|
|
|
|
|
Group Health Implementation of Atopic Dermatitis Algorithm |
Atopic Dermatitis Algorithm |
Group Health Cooperative |
Case, Control |
206 |
207 |
100%, 100% |
100% |
|
CHOP implementation of Atopic Dermatitis |
Atopic Dermatitis Algorithm |
CHOP |
Case, Control |
|
|
92%, 96% |
|
|
Nortwestern University e3 Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Northwestern University |
Case, Control |
48 |
133 |
|
|
|
Updated Geisinger Impl |
CAAD (Carotid Artery Atherosclerosis Disease) |
Geisinger |
Case, Control |
|
|
|
|
|
Marshfield implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Marshfield Clinic Research Foundation |
Case, Control |
71 |
435 |
100%, 100% |
100% |
|
Group Health/University of Washington CAAD Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Group Health/University of Washington |
Case, Control |
300 |
4,475 |
96%, 100% |
|
|
Marshfield Implementation 2 |
CAAD (Carotid Artery Atherosclerosis Disease) |
Marshfield Clinic Research Foundation |
Case, Control |
193 |
4,170 |
100%, 100% |
|
|
Mayo Clinic CAAD Evaluation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Mayo Clinic |
Case, Control |
|
|
100% |
72% |
|
Mayo CAAD cases and controls |
CAAD (Carotid Artery Atherosclerosis Disease) |
Mayo |
Case, Control |
13 |
|
100% |
71% |
|
Mount Sinai Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Mount Sinai School of Medicine |
Case, Control |
105 |
5,180 |
|
|
|
Geisinger CAAD Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Geisinger |
Case, Control |
|
|
|
|
